ASGCT 2024: Navigating the sea of gene and cell therapies
Molecular Therapy · 2024
DOI: 10.1016/j.ymthe.2024.06.013 ↗Kurz gefasst
Editorial in der Zeitschrift Molecular Therapy, 2024. Verfasst von Roland W Herzog und 1 weiteren Autor:innen. Beteiligte Einrichtung: Editor-in-Chief, Molecular Therapy. Hauptthemen laut MEDLINE: Genetic Therapy, Cell- and Tissue-Based Therapy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As the field of gene and cell therapy has grown and matured over the past decade, the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting has also witnessed significant growth, and the 2024 Annual Meeting was no exception. Nearly 2000 abstracts were presented this year (1,983 total), representing a 12% increase over 2023. Each day was packed with sessions covering everything from AAV gene therapy to cancer immunotherapy to updates in the regulatory and manufacturing sectors. Recognizing the challenges posed by a growing number of scientific symposia, oral abstract presentations, and fireside chats, the Society introduced session paths for the first time to help attendees successfully navigate all of the content on display at the Annual Meeting. These paths included Cancer, Clinical Science, Gene Editing, Regulatory and Government Affairs, and Viral Vectors, in addition to First-Time Attendees.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Editor-in-Chief, Molecular Therapy.
- Scientific Editor, Molecular Therapy family of journals. Electronic address: rbrickeranthony@asgct.org.
Zitieren
APA
Herzog, R. W., & Bricker-Anthony, R. (2024). ASGCT 2024: Navigating the sea of gene and cell therapies. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.06.013
Vancouver
Herzog RW, Bricker-Anthony R. ASGCT 2024: Navigating the sea of gene and cell therapies. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.06.013
BibTeX
@article{Herzog2024,
author = {Herzog, Roland W and Bricker-Anthony, Rory},
title = {ASGCT 2024: Navigating the sea of gene and cell therapies},
journal = {Molecular Therapy},
year = {2024},
doi = {10.1016/j.ymthe.2024.06.013}
}
EUVIMED